NAKASHIMA, Shota et al. Development of imatinibmesylate-induced interstitial lung disease 2 weeks after discontinuation of the treatment: a case report. Multidisciplinary Respiratory Medicine, [S. l.], v. 7, 2012. DOI: 10.4081/mrm.2012.635. Disponível em: https://mrmjournal.org/index.php/mrm/article/view/635.. Acesso em: 7 jul. 2024.